TheraRadar
← Back
Data updated: Mar 29, 2026

IMPAX LABS

NeurologyCardiovascularMetabolic
Generics

IMPAX LABS is a generic drug manufacturer focused on Neurology, Cardiovascular, Metabolic. Key products include RYTARY.

1967
Since
116
Drugs
-
Trials
1060
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 33%
5 drugs Phase 3: 3 Phase 2: 2 Phase 1: 1
Cardiovascular 26%
6 drugs Phase 1: 1
Metabolic 17%
4 drugs
Infectious Disease 17%
4 drugs
Immunology 8%
2 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...